Injectable Collagenase and Percutaneous Needle Fasciotomy for Dupuytren's Contracture
NCT ID: NCT01538017
Last Updated: 2016-10-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2012-02-29
2016-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Treatment Of Dupuytren's Contracture With Collagenase Clostridium Histolyticum Injection (Xiapex)
NCT01229436
Collagenase Injection vs Percutaneous Needle Aponeurotomy for Dupuytren's Disease
NCT03000114
Collagenase is a Common Treatment of MCP and PIP Joint Contractures in Dupuytrens Disease
NCT03331926
Fasciectomy vs Collagenase Injection in Recurrent Dupuytren Disease
NCT03406338
Dupuytren´s Disease Study. Primary Disease, MCP Joint, Xiapex, PNF
NCT02647619
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Collagenase injection
Injection of collagenase obtained from Clostridium Histolyticum in contracture string
Xiapex
Collagenase Clostridium Histolyticum
Percutaneous needle fasciotomy
PNF ad modum Lermusiaux and Debeyre
Percutaneous needle fasciotomy
Percutaneous needle fasciotomy ad modum Lermusiaux and Debeyre
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Xiapex
Collagenase Clostridium Histolyticum
Percutaneous needle fasciotomy
Percutaneous needle fasciotomy ad modum Lermusiaux and Debeyre
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Clearly defined strings
Exclusion Criteria
* International Normalised Ratio more than 2.0
* Pregnancy and breastfeeding
* Previous treatment for DC in affected finger
* Former inclusion in the study with another string
* Activity in disease at time of study
* PED more than 20 degrees for Metacarpophalangeal or Distal Interphalangeal joint in affected digit
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jeppe Lange, MD
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jeppe Lange, MD
M:D:
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jeppe Lange, M.D.
Role: STUDY_DIRECTOR
Regionshospitalet Silkeborg
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Center for Planned surgery - Regionalhospital Silkeborg
Silkeborg, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
M-20110233
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.